Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
6.84
+0.63 (10.14%)
At close: Jun 26, 2026, 4:00 PM EDT
6.71
-0.13 (-1.90%)
After-hours: Jun 26, 2026, 7:49 PM EDT
Verrica Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Verrica Pharmaceuticals stock have an average target of 16.33, with a low estimate of 12 and a high estimate of 20. The average target predicts an increase of 138.74% from the current stock price of 6.84.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 26, 2026.
Analyst Ratings
The average analyst rating for Verrica Pharmaceuticals stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $12 | Buy | Initiates | $12 | +75.44% | May 26, 2026 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 13, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $20 | Buy | Maintains | $20 | +192.40% | May 13, 2026 |
| Brookline Capital Markets | Brookline Capital Markets | Buy Upgrades $17 | Buy | Upgrades | $17 | +148.54% | Dec 18, 2025 |
Financial Forecast
Revenue This Year
25.53M
from 35.58M
Decreased by -28.24%
Revenue Next Year
46.26M
from 25.53M
Increased by 81.20%
EPS This Year
-1.73
from -1.24
EPS Next Year
-1.24
from -1.73
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 31.0M | 62.2M | |
| Avg | 25.5M | 46.3M | |
| Low | 20.2M | 26.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -12.9% | 143.6% | |
| Avg | -28.2% | 81.2% | |
| Low | -43.3% | 1.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.57 | -0.87 | |
| Avg | -1.73 | -1.24 | |
| Low | -1.83 | -1.71 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.